 |
| 5.6.2015 | AGENDA |
| | . |
| 1:30 – 2:30 | Registration & Networking |
| 2:30 – 2:40 | Welcome & Opening Remarks
Gary Gilliland, President & Director, Fred Hutchinson Cancer Research Center
Jim Edwards, Publisher, Xconomy |
| 2:40 – 3:00 | Fred Hutchinson Steps Towards Cures
Gary Gilliland, Fred Hutchinson Cancer Research Center
Alex Lash, National Biotech Editor, Xconomy |
| 3:00 – 3:30 | Innovation’s Source: Seattle’s Nonprofit and Academic Core
Gary Gilliland, Fred Hutchinson Cancer Research Center
Charlotte Hubbert, Program Investment Officer, The Bill & Melinda Gates Foundation
Vikram Jandhyala, Vice Provost for Innovation, CoMotion
David Poston, COO, Allen Institute
Alex Lash, National Biotech Editor, Xconomy (Moderator) |
| 3:30 – 3:50 | T-Cell Therapies Hit The Clinic (Cancer Immunotherapy, Part 1)
Hans Bishop, CEO, Juno Therapeutics
Carlos Paya, CEO, Immune Design |
| 3:50 – 4:20 | Local for the Long Haul: Building Seattle’s Anchor Biotechs
Eric Dobmeier, COO, Seattle Genetics
Heather Franklin, CEO, Blaze Bioscience
Randy Schatzman, CEO, Alder Biotherapeutics
Mike Gallatin, Senior Advisor, Frazier Healthcare (Moderator) |
| 4:20 – 4:45 | Networking Break
|
| 4:45 – 5:00 | Adaptive Bulks Up (Cancer Immunotherapy, Part 2)
Chad Robins, CEO, Adaptive Biotechnologies |
| 5:00 – 5:25 | Square-Off: Biotech vs. Tech (But Also, Biotech + Tech)
Robert Nelsen, Managing Director, ARCH Venture Partners
Matt Mcllwain, Managing Director, Madrona Venture Group |
| 5:25 – 5:45 | 21st Century Wellness, and How to Get There
Lee Hood, President, The Institute for Systems Biology
Alex Lash, National Biotech Editor, Xconomy |
| 5:45 – 6:45 | Networking Reception |
